上海建工(600170.SH)中標32.22億元張江中區58-01地塊項目
格隆匯3月24日丨上海建工(600170.SH)公佈,近日,公司全資子公司上海建工一建集團有限公司收到張江中區58-01地塊項目工程施工中標通知書。
項目中標價為人民幣32.22億元。項目位於上海市浦東新區,東至規劃58-03地塊、西至規劃卓聞路、南至規劃58-02地塊、北至規劃海科路。項目總建築面積31.29萬平方米,包括4幢樓房及4層地下室,其中地上面積22.84萬平方米、地下面積8.45萬平方米,預計施工工期為1825日曆天。
項目中標體現了公司在高端商務樓宇、高端酒店建築工程施工承包領域的競爭優勢及項目執行能力,項目的順利實施將對公司的未來業績產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.